期刊文献+

丙型肝炎患者HCV RNA载量、肝脏纤维化指数与25羟基维生素D水平的相关性分析 被引量:10

Analysis on the correlations of 25-hydroxyvitamin D concentrations with HCV RNA loads and cirrhosis severity in hepatitis C patients
下载PDF
导出
摘要 目的分析丙型肝炎(简称丙肝)患者血清25羟基维生素D[25(OH)D]水平和病毒载量、肝脏纤维化程度之间的关系。方法收集271例丙肝患者和218名表面健康人(正常对照组)的血清标本,定量检测血清25(OH)D浓度、HCV RNA病毒载量以及Fibrotest分级标准中的5项指标[包括α2巨球蛋白(α2M)、触珠蛋白(HPT)、载脂蛋白A1(apo A1)、总胆红素(TBil)和γ-谷氨酰基转移酶(GGT)]。根据Fibrotest分级标准判断丙肝患者的肝纤维化程度。比较丙肝组与正常对照组之间25(OH)D浓度的差异;比较HCV RNA阳性组与阴性组25(OH)D浓度的差异;分析HCV RNA阳性组HCV RNA载量与25(OH)D浓度的相关性。根据25(OH)D浓度进行四分位分组,分析25(OH)D浓度与肝脏纤维化指数(Fibrotest分级)的关系。结果丙肝组25(OH)D浓度为(49.31±1.39)nmol/L,明显低于正常对照组[(60.42±1.34)nmol/L,P<0.01]。丙肝组中25(OH)D缺乏(<50 nmol/L)和严重缺乏(<25 nmol/L)的比例为41.33%(112/271)和14.40%(39/271),明显高于正常对照组[27.98%(61/218)和3.67%(8/218)](P<0.01)。丙肝患者中HCV RNA阳性组与HCV RNA阴性组25(OH)D浓度分别为48.98±21.59、(49.89±25.27)nmol/L,两组比较差异无统计学意义(P>0.05)。线性相关分析显示HCV RNA阳性组病毒载量对数值与其25(OH)D浓度无相关性(r=0.056,P=0.412)。四分位25(OH)D最低浓度分位和最高浓度分位患者的Fibrotest分级F0-F1级、F1-F3级和F3-F4级的比例差异无统计学意义(P>0.05);无肝纤维化、轻度肝纤维化、重度肝纤维化患者25(OH)D浓度分别为49.12±5.80、48.27±4.90和(49.89±8.20)nmol/L,3组之间差异无统计学意义(P>0.05)。结论丙肝患者体内25(OH)D浓度明显低于健康对照人群,建议对该类人群进行维生素D的补充。丙肝患者25(OH)D浓度与HCV RNA载量及肝纤维化的严重程度并不明显相关。 Objective To investigate the correlations of serum 25-hydroxyvitamin D [25( OH) D]concentrations with hepatitis C virus( HCV) RNA loads and cirrhosis severity in hepatitis C patients. Methods A total of 271 hepatitis C patients and 218 healthy subjects were enrolled,and their serum samples were collected. Serum 25( OH) D concentrations and HCV RNA loads were determined. Moreover,serum alpha 2-macroglobulin( α2M),haptoglobin(HPT),apolipoprotein A1(apo A1),total bilirubin(TBil) and gamma-glutamyl transpeptidase(GGT) concentrations were determined. According to Fibrotest classification, the severity of cirrhosis was evaluated. The 25( OH) D concentrations between hepatitis C and healthy control groups were compared. Furthermore,the difference of serum25( OH) D between HCV RNA positive group and HCV RNA negative group was also evaluated. The correlation between serum 25( OH) D concentrations and HCV RNA loads in HCV RNA positive group was analyzed. Hepatitis C patients were classified according to the quartile concentrations of 25( OH) D,and the correlation between serum 25( OH) D concentrations and Fibrotest classification was investigated. Results Serum 25( OH) D concentrations were significantly higher in healthy control group than in hepatitis C group [means were( 60. 42 ± 1. 34) nmol / L and( 49. 31 ±1. 39) nmol / L,P〈0. 01]. The proportions of patients with the deficiency of 25( OH) D( 50 nmol / L) and the ones with severe deficiency( 〈25 nmol / L) in hepatitis C group were 41. 33%( 112 /271) and 14. 40%( 39 /271),which were significantly higher than those in healthy control group[27. 98%(61 /218) and 3. 67%(8 /218)]( P〈0. 01).No significant difference for serum 25( OH) D concentrations was observed between HCV RNA positive and HCV RNA negative groups[means were 48. 98 ± 21. 59 and(49. 89 ± 25. 27) nmol / L,P〉0. 05]. Linearity regression revealed that there was no correlation between the logarithmic of HCV RNA loads and the concentration of 25( OH) D in HCV RNA positive group( r = 0. 056,P = 0. 412). Moreover,there was no statistical significance for the proportion of patients with different Fibrotest classifications( F0-F1,F1-F3 and F3-F4) between the highest quartile concentration and the lowest quartile concentration of 25( OH) D [means were 49. 12 ± 5. 80,48. 27 ± 4. 90 and(49. 89 ± 8. 20) nmol / L,P〉0. 05]. Conclusions The hepatitis C patients are prone to encounter 25( OH) D deficiency compared with healthy subjects,which implys that these patients are suggested to uptake vitamin D supply. Furthermore,no clinical correlation is found between the logarithmic of HCV RNA loads,cirrhosis severity and the concentrations of 25( OH) D.
出处 《检验医学》 CAS 2015年第6期575-580,共6页 Laboratory Medicine
基金 "十二五"国家科技支撑计划资助项目(2012BAI37B01) 国家临床重点检验专科建设资助项目
关键词 25羟基维生素D 丙型肝炎 丙型肝炎病毒 Fibrotest分级 25-hydroxyvitamin D Hepatitis C Hepatitis C virus Fibrotest classification
  • 相关文献

参考文献4

二级参考文献69

  • 1Hay JE.Osteoporosis in liver diseases and after liver transplantation.J Hepatol 2003; 38:856-865.
  • 2Collier JD,Ninkovic M,Compston JE.Guidelines on the management of osteoporosis associated with chronic liver disease.Gut 2002; 50 Suppl 1:i1-i9.
  • 3Hay JE,Guichelaar MM.Evaluation and management of osteoporosis in liver disease.Clin Liver Dis 2005; 9:747-766,viii.
  • 4Sachdev S,Bhasin RC,Kumari CK,Reys M.A study of metabolic bone disorder in cirrhosis liver.J Assoc Physicians India 1976; 24:5-11.
  • 5Barger-Lux MJ,Heaney RP.Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption.J Clin Endocrinol Metab 2002; 87:4952-4956.
  • 6Nutrient requirements and recommended daily allowances for Indians:Report of the expert group of the Indian Council of Medical Research.National Institute of Nutrition,2000:41.
  • 7Leslie WD,Bernstein CN,Leboff MS.AGA technical review on osteoporosis in hepatic disorders.Gastroenterology 2003; 125:941-966.
  • 8Mithal A.Metabolic bone disorders.1st ed.Indian society of bone and mineral research,1998:213 -219.
  • 9Nordin BE.International patterns of osteoporosis.Clin Orthop Relat Res 1966; 45:17-30.
  • 10Vernejoul M.Bone structure and function.In:Geusens P,editor.Osteoporosis in clinical practice.A practical guide for diagnosis and treatment.London:Springer-Verlag,1998:1-4.

共引文献50

同被引文献74

  • 1Livia Melo Villar,José Antonio Del Campo,Isidora Ranchal,Elisabeth Lampe,Manuel Romero-Gomez.Association between vitamin D and hepatitis C virus infection: A meta-analysis[J].World Journal of Gastroenterology,2013,19(35):5917-5924. 被引量:9
  • 2ZHONG N, WANG C, YAO W, et al. Prevalence of chronic obstructive pulmonary disease in China. a large, population-based survey[J]. Am J Respir Crit Care Med, 2007, 176 (8) : 753-760.
  • 3TSILIGIANNI IG, VAN DER MOLEN T. A systematic review of the role of vitamin insufficiencies and supplementation in COPD[J]. Respir Res, 2010, 11: 171.
  • 4ZASLOFF M. Antimicrobial peptides of multicellular organisms[J]. Nature, 2002, 415 ( 6870 ) : 389-395.
  • 5WANG TT, NESTEL FP, BOURDEAU V, et al. Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression[J]. J Immunol, 2004, 173 (5) : 2909-2912.
  • 6GORDON Y J, HUANG LC, ROMANOWSKI EG, et al. Human cathelicidin (LL-37) , a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity[J]. Curt Eye Res, 2005, 30 ( 5 ) : 385-394.
  • 7BERRY D J, HESKETH K, POWER C, et al. Vitamin D status has a linear association with seasonal infections and lung function in British adults[J]. Br J Nutr, 2011, 106 (9) : 1433-1440.
  • 8LAU B, SHARRETTAR, KINGSLEY LA, et al. C-reactive protein is a marker for human immunodeficiency virus disease progression[J]. Arch InternMed, 2006, 166 ( 1 ) : 64-70.
  • 9隗荣华,李淑莉,刘薇,曾令兰.荧光定量PCR法在丙型肝炎病毒核糖核酸检测中的应用[J].中西医结合肝病杂志,2008,18(5):301-303. 被引量:3
  • 10付强,况九龙,施德全.C反应蛋白在慢性阻塞性肺疾病急性加重期中的临床意义[J].国际呼吸杂志,2009,29(15):897-900. 被引量:14

引证文献10

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部